Advertisement

Acute Generalized Exanthematous Pustulosis

  • Alexis Sidoroff
  • AGEP, mostly caused by drugs, is characterized by the acute occurrence of numerous sterile pinhead-sized pustules on an oedematous erythema accompanied by fever and leucocytosis.

  • The drugs with the highest risk to cause AGEP are antibacterial agents like ampicillin/amoxicillin, and quinolones, pristinamycin, anti-infective sulfonamides, the antimycotic drug terbinafine, (hydroxy)chloroquine, and diltiazem, but a large number of other drugs as well as infections have been reported as triggers.

  • AGEP is an acute and sometimes severe reaction, but resolves quickly and without special treatment when the culprit drug is withdrawn.

Keywords

Toxic Epidermal Necrolysis Pustular Psoriasis Acute Generalize Exanthematous Pustulosis Chromium Picolinate Culprit Drug 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Macmillan AL. Generalised pustular drug rash. Dermatologica 1973 146(5):285–91.PubMedGoogle Scholar
  2. 2.
    Staughton RC, Payne CM, Harper JI, et al. Toxic pustulo-derma-a new entity? J R Soc Med 1984 77(Suppl 4):6–8.PubMedGoogle Scholar
  3. 3.
    Beylot C, Bioulac P, Doutre MS. [Acute generalized exan-thematic pustuloses (four cases) (author's transl)]. Ann Dermatol Venereol 1980 107(1–2):37–48.PubMedGoogle Scholar
  4. 4.
    Auer-Grumbach P, Pfaffenthaler E, Soyer HP. Pustulosis acuta generalisata is a post-streptococcal disease and is distinct from acute generalized exanthematous pustulosis. Br J Dermatol 1995 133(1):135–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Braun-Falco O, Luderschmidt C, Maciejewski W, et al. [Generalized acute pustulosis. An unusual presentation of leukocytoclastic vasculitis]. Hautarzt 1978 29(7):371–7.PubMedGoogle Scholar
  6. 6.
    Patrizi A, Savoia F, Giacomini F, et al. Diffuse acute pustular eruption after streptococcal infection – a new instance of pus-tulosis acuta generalisata. Pediatr Dermatol 2007 24(3):272–6.PubMedCrossRefGoogle Scholar
  7. 7.
    Sidoroff A, Halevy S, Bavinck JN, et al. Acute generalized exanthematous pustulosis (AGEP) – a clinical reaction pattern. J Cutan Pathol 2001 28(3):113–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Roujeau JC, Bioulac-Sage P, Bourseau C, et al. Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol 1991 127(9):1333–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Eeckhout I, Noens L, Ongenae K, et al. Acute generalized exanthematic pustulosis: a case with a lymphoma-like presentation. Dermatology 1997 194(4):408–10.PubMedGoogle Scholar
  10. 10.
    Burrows NP, Russell Jones RR. Pustular drug eruptions: a his-topathological spectrum. Histopathology 1993 22(6):569–73.PubMedCrossRefGoogle Scholar
  11. 11.
    Cohen AD, Cagnano E, Halevy S. Acute generalized exan-thematous pustulosis mimicking toxic epidermal necrolysis. Int J Dermatol 2001 40(7):458–61.PubMedCrossRefGoogle Scholar
  12. 12.
    Meiss F, Helmbold P, Meykadeh N, et al. Overlap of acute generalized exanthematous pustulosis and toxic epidermal necrolysis: response to antitumour necrosis factor–alpha antibody infliximab: report of three cases. J Eur Acad Dermatol Venereol 2007 21(5):717–9.PubMedGoogle Scholar
  13. 13.
    Sidoroff A, Dunant A, Viboud C, et al. Risk factors for acute generalized exanthematous pustulosis (AGEP) – results of a multinational case-control study (EuroSCAR). Br J Dermatol 2007 157(5):989–96.PubMedCrossRefGoogle Scholar
  14. 14.
    Beylot C, Doutre MS, Beylot-Barry M. Acute generalized exanthematous pustulosis. Semin Cutan Med Surg 1996 15(4):244–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Rockl H. [Leukocytoclastic vasculitis due to drug allergy presenting as generalized pustular exanthema]. Hautarzt 1981 32(9):467–70.PubMedGoogle Scholar
  16. 16.
    Strutton G, Weedon D, Robertson I. Pustular vasculitis of the hands [see comments]. J Am Acad Dermatol 1995 32(2 Pt 1):192–8.PubMedCrossRefGoogle Scholar
  17. 17.
    Tamir E, Wohl Y, Mashiah J, et al. Acute generalized exan-thematous pustulosis: a retrospective analysis showing a clear predilection for women. Skinmed 2006 5(4):186–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Brenner S, Wohl Y. Acute generalized exanthematous pustu-losis in pregnancy: more common than previously estimated. Skin Med 2005 4(6):336.CrossRefGoogle Scholar
  19. 19.
    Wohl Y, Goldberg I, Sharazi I, et al. A case of paracetamol-induced acute generalized exanthematous pustulosis in a pregnant woman localized in the neck region. Skin Med 2004 3(1):47–9.CrossRefGoogle Scholar
  20. 20.
    Bernard P, Lizeaux-Parneix V, Miossec V, et al. HLA et prédisposition génétique dans les pustuloses exanthéma-tiques (PEAG) et les exanthémes maculo-papuleux (EMP). Ann Dermatol Venereol 1995 122:S38–S39.Google Scholar
  21. 21.
    Saissi EH, Beau-Salinas F, Jonville-Bera AP, et al. [Drugs associated with acute generalized exanthematic pustulosis]. Ann Dermatol Venereol 2003 130(6–7):612–8.PubMedGoogle Scholar
  22. 22.
    Feio AB, Apetato M, Costa MM, et al. [Acute generalized exanthematous pustulosis due to Coxsackie B4 virus]. Acta Med Port 1997 10(6–7):487–91.PubMedGoogle Scholar
  23. 23.
    Haro-Gabaldon V, Sanchez-Sanchez-Vizcaino J, Ruiz-Avila P, et al. Acute generalized exanthematous pustulosis with cyto-megalovirus infection. Int J Dermatol 1996 35(10):735–7.PubMedCrossRefGoogle Scholar
  24. 24.
    Manzano S, Guggisberg D, Hammann C, et al. [Acute generalized exanthematous pustulosis: first case associated with a Chlamydia pneumoniae infection]. Arch Pediatr 2006 13(9):1230–2.PubMedCrossRefGoogle Scholar
  25. 25.
    Naides SJ, Piette W, Veach LA, et al. Human parvovirus B19-induced vesiculopustular skin eruption. Am J Med 1988 84(5):968–72.PubMedCrossRefGoogle Scholar
  26. 26.
    Ofuji S, Yamamoto O. Acute generalized exanthematous pustulosis associated with a human parvovirus B19 infection. J Dermatol 2007 34(2):121–3.PubMedCrossRefGoogle Scholar
  27. 27.
    Rouchouse B, Bonnefoy M, Pallot B, et al. Acute generalized exanthematous pustular dermatitis and viral infection. Dermatologica 1986 173(4):180–4.PubMedCrossRefGoogle Scholar
  28. 28.
    Britschgi M, Pichler WJ. Acute generalized exanthematous pustulosis, a clue to neutrophil-mediated inflammatory processes orchestrated by T cells. Curr Opin Allergy Clin Immunol 2002 2(4):325–31.PubMedCrossRefGoogle Scholar
  29. 29.
    Britschgi M, Steiner UC, Schmid S, et al. T-cell involvement in drug-induced acute generalized exanthematous pustulo-sis. J Clin Invest 2001 107(11):1433–41.PubMedCrossRefGoogle Scholar
  30. 30.
    Britschgi M, von Greyerz S, Burkhart C, et al. Molecular aspects of drug recognition by specific T cells. Curr Drug Targets 2003 4(1):1–11.PubMedCrossRefGoogle Scholar
  31. 31.
    Pichler WJ. T cells in drug allergy. Curr Allergy Asthma Rep 2002 2(1):9–15.PubMedCrossRefGoogle Scholar
  32. 32.
    Schmid S, Kuechler PC, Britschgi M, et al. Acute generalized exanthematous pustulosis: role of cytotoxic T cells in pustule formation. Am J Pathol 2002 161(6):2079–86.PubMedGoogle Scholar
  33. 33.
    Greco M, Plantin P. Acute generalized exanthematous pustulosis (AGEP) induced by terbinafine with involuntary positive reintroduction. Eur J Dermatol 2005 15(2):116.PubMedGoogle Scholar
  34. 34.
    Barbaud A. Drug patch testing in systemic cutaneous drug allergy. Toxicology 2005 209(2):209–16.PubMedCrossRefGoogle Scholar
  35. 35.
    Wolkenstein P, Chosidow O, Flechet ML, et al. Patch testing in severe cutaneous adverse drug reactions, including Stevens–Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis 1996 35(4):234–6.PubMedCrossRefGoogle Scholar
  36. 36.
    Mashiah J, Brenner S. A systemic reaction to patch testing for the evaluation of acute generalized exanthematous pustulosis. Arch Dermatol 2003 139(9):1181–3.PubMedCrossRefGoogle Scholar
  37. 37.
    Lazarov A, Livni E, Halevy S. Generalized pustular drug eruptions: confirmation by in vitro tests. J Eur Acad Dermatol Venereol 1998 10(1):36–41.PubMedCrossRefGoogle Scholar
  38. 38.
    Lazarov A, Livni E, Halevy S. Generalized pustular drug eruptions: confirmation by in vitro tests [see comments]. J Eur Acad Dermatol Venereol 1998 10(1):36–41.PubMedCrossRefGoogle Scholar
  39. 39.
    Halevy S, Cohen A, Livni E. Acute generalized exanthema-tous pustulosis associated with polysensitivity to paracetamol and bromhexine: the diagnostic role of in vitro interferon–gamma release test. Clin Exp Dermatol 2000 25(8):652–4.PubMedCrossRefGoogle Scholar
  40. 40.
    Beltraminelli HS, Lerch M, Arnold A, et al. Acute generalized exanthematous pustulosis induced by the antifungal terbinafine: case report and review of the literature. Br J Dermatol 2005 152(4):780–3.PubMedCrossRefGoogle Scholar
  41. 41.
    Girardi M, Duncan KO, Tigelaar RE, et al. Cross-comparison of patch test and lymphocyte proliferation responses in patients with a history of acute generalized exanthematous pustulosis. Am J Dermatopathol 2005 27(4):343–6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2009

Authors and Affiliations

  • Alexis Sidoroff
    • 1
  1. 1.Department of Dermatology and VenereologyMedical University of InnsbruckInnsbruckAustria

Personalised recommendations